List of Tables
Table 1. Global Central Nervous System (CNS) Stimulant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Central Nervous System (CNS) Stimulant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Central Nervous System (CNS) Stimulant Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Central Nervous System (CNS) Stimulant Drugs Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Central Nervous System (CNS) Stimulant Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Central Nervous System (CNS) Stimulant Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Central Nervous System (CNS) Stimulant Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Central Nervous System (CNS) Stimulant Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Central Nervous System (CNS) Stimulant Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Central Nervous System (CNS) Stimulant Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System (CNS) Stimulant Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Stimulant Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System (CNS) Stimulant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Central Nervous System (CNS) Stimulant Drugs Sales by Region (2019-2024) & (MT)
Table 18. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Central Nervous System (CNS) Stimulant Drugs Sales by Region (2025-2030) & (MT)
Table 20. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Central Nervous System (CNS) Stimulant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2019-2024) & (MT)
Table 27. North America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2025-2030) & (MT)
Table 28. North America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Central Nervous System (CNS) Stimulant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Country (2019-2024) & (MT)
Table 32. Europe Central Nervous System (CNS) Stimulant Drugs Sales by Country (2025-2030) & (MT)
Table 33. Europe Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Central Nervous System (CNS) Stimulant Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Central Nervous System (CNS) Stimulant Drugs Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Central Nervous System (CNS) Stimulant Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Central Nervous System (CNS) Stimulant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2019-2024) & (MT)
Table 42. Latin America Central Nervous System (CNS) Stimulant Drugs Sales by Country (2025-2030) & (MT)
Table 43. Latin America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Central Nervous System (CNS) Stimulant Drugs Sales (MT) by Type (2019-2024)
Table 51. Global Central Nervous System (CNS) Stimulant Drugs Sales (MT) by Type (2025-2030)
Table 52. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT) by Type (2019-2024)
Table 59. Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT) by Type (2025-2030)
Table 60. Global Central Nervous System (CNS) Stimulant Drugs Sales (MT) by Application (2019-2024)
Table 61. Global Central Nervous System (CNS) Stimulant Drugs Sales (MT) by Application (2025-2030)
Table 62. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT) by Application (2019-2024)
Table 69. Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT) by Application (2025-2030)
Table 70. Astellas Pharma Corporation Information
Table 71. Astellas Pharma Description and Business Overview
Table 72. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Product
Table 74. Astellas Pharma Recent Developments/Updates
Table 75. Biogen Corporation Information
Table 76. Biogen Description and Business Overview
Table 77. Biogen Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Biogen Central Nervous System (CNS) Stimulant Drugs Product
Table 79. Biogen Recent Developments/Updates
Table 80. Celltech Corporation Information
Table 81. Celltech Description and Business Overview
Table 82. Celltech Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Celltech Central Nervous System (CNS) Stimulant Drugs Product
Table 84. Celltech Recent Developments/Updates
Table 85. Eli Lilly and Company Corporation Information
Table 86. Eli Lilly and Company Description and Business Overview
Table 87. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Product
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Johnson and Johnson Corporation Information
Table 96. Johnson and Johnson Description and Business Overview
Table 97. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Product
Table 99. Johnson and Johnson Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Merck Central Nervous System (CNS) Stimulant Drugs Product
Table 104. Merck Recent Developments/Updates
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Novartis Central Nervous System (CNS) Stimulant Drugs Product
Table 109. Novartis Recent Developments/Updates
Table 110. Perdue Pharma Corporation Information
Table 111. Perdue Pharma Description and Business Overview
Table 112. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Product
Table 114. Perdue Pharma Recent Developments/Updates
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Pfizer Central Nervous System (CNS) Stimulant Drugs Product
Table 119. Pfizer Recent Developments/Updates
Table 120. Roche Corporation Information
Table 121. Roche Description and Business Overview
Table 122. Roche Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Roche Central Nervous System (CNS) Stimulant Drugs Product
Table 124. Roche Recent Developments/Updates
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Sanofi Central Nervous System (CNS) Stimulant Drugs Product
Table 129. Sanofi Recent Developments/Updates
Table 130. Shire Corporation Information
Table 131. Shire Description and Business Overview
Table 132. Shire Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. Shire Central Nervous System (CNS) Stimulant Drugs Product
Table 134. Shire Recent Developments/Updates
Table 135. Takeda Pharmaceuticals Corporation Information
Table 136. Takeda Pharmaceuticals Description and Business Overview
Table 137. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 138. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Product
Table 139. Takeda Pharmaceuticals Recent Developments/Updates
Table 140. Thermo Fisher Scientific Corporation Information
Table 141. Thermo Fisher Scientific Description and Business Overview
Table 142. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 143. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Product
Table 144. Thermo Fisher Scientific Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Central Nervous System (CNS) Stimulant Drugs Distributors List
Table 148. Central Nervous System (CNS) Stimulant Drugs Customers List
Table 149. Central Nervous System (CNS) Stimulant Drugs Market Trends
Table 150. Central Nervous System (CNS) Stimulant Drugs Market Drivers
Table 151. Central Nervous System (CNS) Stimulant Drugs Market Challenges
Table 152. Central Nervous System (CNS) Stimulant Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Central Nervous System (CNS) Stimulant Drugs
Figure 2. Global Central Nervous System (CNS) Stimulant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Type in 2023 & 2030
Figure 4. Amphetamine Product Picture
Figure 5. Cocaine Product Picture
Figure 6. Caffeine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Central Nervous System (CNS) Stimulant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Application in 2023 & 2030
Figure 10. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 11. Narcolepsy
Figure 12. Others
Figure 13. Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Central Nervous System (CNS) Stimulant Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Central Nervous System (CNS) Stimulant Drugs Sales (2019-2030) & (MT)
Figure 16. Global Central Nervous System (CNS) Stimulant Drugs Average Price (USD/MT) & (2019-2030)
Figure 17. Central Nervous System (CNS) Stimulant Drugs Report Years Considered
Figure 18. Central Nervous System (CNS) Stimulant Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Central Nervous System (CNS) Stimulant Drugs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Central Nervous System (CNS) Stimulant Drugs Players: Market Share by Revenue in 2023
Figure 21. Central Nervous System (CNS) Stimulant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Central Nervous System (CNS) Stimulant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2019-2030)
Figure 47. Latin America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Central Nervous System (CNS) Stimulant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Central Nervous System (CNS) Stimulant Drugs by Type (2019-2030)
Figure 57. Global Revenue Market Share of Central Nervous System (CNS) Stimulant Drugs by Type (2019-2030)
Figure 58. Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT) by Type (2019-2030)
Figure 59. Global Sales Market Share of Central Nervous System (CNS) Stimulant Drugs by Application (2019-2030)
Figure 60. Global Revenue Market Share of Central Nervous System (CNS) Stimulant Drugs by Application (2019-2030)
Figure 61. Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT) by Application (2019-2030)
Figure 62. Central Nervous System (CNS) Stimulant Drugs Value Chain
Figure 63. Central Nervous System (CNS) Stimulant Drugs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed